Literature DB >> 24825319

Abnormal alpha-synuclein reduces nigral voltage-dependent anion channel 1 in sporadic and experimental Parkinson's disease.

Yaping Chu1, Jennifer G Goldman2, Leo Kelly2, Yinzhen He2, Tracy Waliczek2, Jeffrey H Kordower3.   

Abstract

Both the misfolding of α-synuclein and mitochondrial dysfunction are considered two major contributors to Parkinson's disease (PD). However, the relationship between the two in normal and PD states remains unclear. Here, we report that voltage-dependent anion channel 1 (VDAC1), a major component of the outer mitochondrial membrane known to regulate mitochondrial functions, is down-regulated in response to α-synuclein accumulation and aggregation. Stereological analysis revealed that 58.33% of the neurons were VDAC1 immunoreactive in the remaining neuromelanin laden neurons in the PD group while 87.48% of the nigral neurons were VDAC1 immunoreactive in the age-matched control group. The relative levels of VDAC1 were significantly decreased in PD nigral neurons when compared to age-matched controls. In PD, this decrease was significantly greater in nigral neurons with α-synuclein inclusions. VDAC1 was observed in fibers with granular α-synuclein but not in fibers with aggregated α-synuclein. Viral vector-mediated overexpression of mutant human α-synuclein (A30P) in rats resulted in significantly decreased VDAC1 in nigral neurons and striatal fibers. These results indicate that mitochondrial function associated with VDAC1 is decreased in sporadic and experimental PD, and this decrease is associated with α-synuclein accumulation and aggregation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Mitochondria; Parkinson's disease; Striatum; Substantia nigra; α-Synuclein

Mesh:

Substances:

Year:  2014        PMID: 24825319     DOI: 10.1016/j.nbd.2014.05.003

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  23 in total

1.  Anti-CD47 monoclonal antibody therapy reduces ischemia-reperfusion injury of renal allografts in a porcine model of donation after cardiac death.

Authors:  Min Xu; Xuanchuan Wang; Babak Banan; Danielle L Chirumbole; Sandra Garcia-Aroz; Aparna Balakrishnan; Deepak K Nayak; Zhengyan Zhang; Jianluo Jia; Gundumi A Upadhya; Joseph P Gaut; Ronald Hiebsch; Pamela T Manning; Ningying Wu; Yiing Lin; William C Chapman
Journal:  Am J Transplant       Date:  2017-12-02       Impact factor: 8.086

Review 2.  Sphingolipids and lipid rafts: Novel concepts and methods of analysis.

Authors:  Erhard Bieberich
Journal:  Chem Phys Lipids       Date:  2018-09-05       Impact factor: 3.329

3.  Do subjects with minimal motor features have prodromal Parkinson disease?

Authors:  Yaping Chu; Aron S Buchman; C Warren Olanow; Jeffrey H Kordower
Journal:  Ann Neurol       Date:  2018-03-10       Impact factor: 10.422

4.  Picroside II Exerts a Neuroprotective Effect by Inhibiting mPTP Permeability and EndoG Release after Cerebral Ischemia/Reperfusion Injury in Rats.

Authors:  Shan Li; Tingting Wang; Li Zhai; Keli Ge; Jun Zhao; Weihong Cong; Yunliang Guo
Journal:  J Mol Neurosci       Date:  2017-12-18       Impact factor: 3.444

5.  The prion hypothesis of Parkinson's disease.

Authors:  Yaping Chu; Jeffrey H Kordower
Journal:  Curr Neurol Neurosci Rep       Date:  2015-05       Impact factor: 5.081

6.  Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient.

Authors:  Jeffrey H Kordower; Christopher G Goetz; Yaping Chu; Glenda M Halliday; Daniel A Nicholson; Timothy F Musial; David J Marmion; A Jon Stoessl; Vesna Sossi; Thomas B Freeman; C Warren Olanow
Journal:  Ann Neurol       Date:  2017-01-06       Impact factor: 10.422

7.  Infiltrative and drug-resistant slow-cycling cells support metabolic heterogeneity in glioblastoma.

Authors:  Lan B Hoang-Minh; Florian A Siebzehnrubl; Changlin Yang; Silveli Suzuki-Hatano; Kyle Dajac; Tyler Loche; Nicholas Andrews; Michael Schmoll Massari; Jaimin Patel; Krisha Amin; Alvin Vuong; Ana Jimenez-Pascual; Paul Kubilis; Timothy J Garrett; Craig Moneypenny; Christina A Pacak; Jianping Huang; Elias J Sayour; Duane A Mitchell; Matthew R Sarkisian; Brent A Reynolds; Loic P Deleyrolle
Journal:  EMBO J       Date:  2018-10-15       Impact factor: 11.598

Review 8.  Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson's Disease-Relevant Phenotypes.

Authors:  S L Sison; S C Vermilyea; M E Emborg; A D Ebert
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-04       Impact factor: 5.081

Review 9.  Sphingolipids in neurodegeneration (with focus on ceramide and S1P).

Authors:  Guanghu Wang; Erhard Bieberich
Journal:  Adv Biol Regul       Date:  2018-09-22

10.  Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes.

Authors:  Yaping Chu; Scott Muller; Adriana Tavares; Olivier Barret; David Alagille; John Seibyl; Gilles Tamagnan; Ken Marek; Kelvin C Luk; John Q Trojanowski; Virginia M Y Lee; Jeffrey H Kordower
Journal:  Brain       Date:  2019-11-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.